Zhejiang Conba Pharmaceutical to appoint new directors after resignations

Zhejiang Conba Pharmaceutical Co., Ltd. will hold its second extraordinary general meeting in 2025 on December 22, 2025, at its Hangzhou office. The meeting's primary agenda is to consider and approve the proposal for appointing new company directors.

The company's board of directors received resignation letters on December 5, 2025, from two directors, Mr. Jiang Yi and Ms. Jiang Qian, due to work adjustments. Mr. Jiang Yi resigned from his roles as director, chairman, and committee memberships, while Ms. Jiang Qian resigned from her director position and audit committee membership.

Following these changes, the board's nomination committee has recommended Mr. Ying Xuyao and Ms. Jin Junli as non-independent director candidates for the eleventh board of directors. Both candidates have been vetted and meet the required qualifications, with their appointments effective upon shareholder approval until the current board's term expires.